Description of Medical ServiceOCT is a non-invasive ophthalmic imaging technique, which provides high-resolution cross-sectional images of the macula, allowing identification of changes due to ophthalmologic conditions. OCT is based on the light reflectance properties of the tissue and provides tissue morphology imagery at higher resolution (better than 10 Ám) than other imaging modalities such as MRI or ultrasound.
OCT is intended to be used for diagnosis and monitoring of retinal diseases in a specialist ophthalmologic setting. It is used in conjunction with visual acuity assessments, clinical examination and fluorescein angiography.
Description of Medical ConditionDiabetic retinopathy is defined as the presence of typical retinal microvascular lesions in persons with diabetes mellitus. DMO, a specific form of diabetic retinopathy, is usually defined as a retinal thickening within two disc diameters of the macula.
DMO is associated with damage to the microvasculature, including retinal haemorrhages, exudates, micro-aneurysms, microvascular abnormalities and areas of capillary closure; leading to the accumulation of fluid and serum macromolecules in the intercellular space. As a result, thickening of the retina and fovea can occur, leading to disturbances in visual acuity.
Reason for ApplicationNew MBS item
Medical Service TypeCo-dependent technology
Previous Application NumberNot Applicable
PICO ConfirmationFinal Protocol (PDF 533 KB)
Final Protocol (Word 860 KB)
Public Summary DocumentApril 2015 MSAC Consideration:
Public Summary Document (PDF 463 KB)
Public Summary Document (Word 1449 KB)
March 2016 MSAC Consideration:
Public Summary Document (PDF 133 KB)
Public Summary Document (Word 75 KB)
OCT broader implementation issues - MSAC's advice to the Minister:
OCT broader implementation issues (PDF 66 KB)
OCT broader implementation issues (Word 66 KB)
Meetings for this Application
PASC16 - 17 April 2014
14 - 15 August 2014
ESC12 - 13 February 2015
MSAC1 - 2 April 2015
30 - 31 March 2016